Annie-Claire Nadeau-Fredette

Slides:



Advertisements
Similar presentations
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Advertisements

A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
PERITONEAL MEMBRANE CHARACTERISTICS IN SAUDI PATIENTS Prof. Jamal Alwakeel, Dr Saira Usama Dr Abdulkareem Alsuwaida, Dr Mohammad AL Ghonaim, Dr Akram.
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Disparities Within and Between Hospitals for Inpatient Quality of Care: Targeting Resources to Close the Gap Romana Hasnain-Wynia, PhD Director, Center.
A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.
Obesity in the end stage kidney disease population
Associate Professor, Honorary Consultant Cardiologist
Presented at CARSP Conference
Evaluating the Effectiveness of Social Work Interventions:
- Higher SBP visit-to-visit variability (SBV) has been associated
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
The SPRINT Research Group
When Using DOPPS Slides
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
Kidney Transplantation and Wait-Listing Rates from the International Dialysis Outcomes and Practice Patterns Study (DOPPS)
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
When Using DOPPS Slides
First-year death rates by modality figure 8
The MASS-DAC Study.
Patient Registries and Health Outcomes in Diabetes: A Retrospective Study Nipa Shah, MD1; Fern Webb, PhD1; Liane Hannah, BSH1; Carmen Smotherman, MS2;
PCI related in-hospital mortality based on race and gender in the USA
The ADEMEX Trial Adequacy of PD in Mexico Reference
Odd ratio of developing kidney failure figure 1
Using extrapolation to support a pediatric investigational plan: an application in liver transplantation development Thomas Dumortier, Martin Fink, Ovidiu.
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Mortality rates in incident ESRD patients figure 9
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
UK Renal Registry 18th Annual Report
BACKGROUND RESULTS OBJECTIVES METHODS CONCLUSIONS REFERENCES
Lecture 4: Meta-analysis
The CANUSA Trial Reference
Critical Reading of Clinical Study Results
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
Systolic Blood Pressure Intervention Trial (SPRINT)
Kuwabara et al. Am J Nephrol 2017;45:   (DOI: / )
on behalf of the LEADER Trial Steering Committee and Investigators
Subsequent Healthcare Utilization Associated With Early Physical Therapy for New Episodes of Low Back Pain in Older Adults Deven Karvelas, MD University.
Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Volume 85, Issue 1, Pages (January 2014)
Volume 86, Issue 4, Pages (October 2014)
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Abstract Decreased Inappropriate Antibiotic Use Following a Korean National Policy to Prohibit Medication Dispensing by Physicians Sylvia Park, PhD; Stephen.
Volume 73, Issue 8, Pages (April 2008)
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Volume 60, Issue 3, Pages (September 2001)
Presentation data from US VICTORY Consortium
Pregnancy outcomes in kidney transplant recipients
Dialysis outcomes in Australia & New Zealand
Body Composition and All-Cause Mortality in Hemodialysis Patients
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
ANZDATA: Vascular Access
Catheter Type, Placement, and Insertion Techniques for Preventing Catheter-Related Infections in Maintenance Peritoneal Dialysis Patients: Summary of.
Presentation transcript:

Annie-Claire Nadeau-Fredette Examination of Centre Effects using the ANZData registry ANZSN 53rd ASM Darwin 5th September Carmel Hawley On behalf of Annie-Claire Nadeau-Fredette Htay Htay David Johnson Elaine Pascoe Yeoungjee Cho PD working group ANZData Registry team The AKTN operates within the UQ School of Medicine’s Centre for Kidney Disease Research (CKDR).

Peritoneal Dialysis centre effects’ analyses Significant variation in PD outcomes is known to exist Identifying centre practices associated with outcomes is important as these practices may be modifiable and be relevant to quality improvement Aim: To determine the relative contributions of patient characteristics and dialysis centre characteristics Hypothesis: Centre factors are an important contributor to variation in important PD outcomes

Methods PD outcomes of interest examined Incidence of peritonitis: published Technique failure : published Outcome of peritonitis : under review Statistical method 2 level mixed effects models with random intercept for dialysis centres Fixed effects were patient and centre characteristics

Methods Study populations Australian incident PD patients ANZData registry 2003-2013 (peritonitis) 2004-2014 (technique failure; cure of peritonitis) 51 centres: 8711 (Peritonitis); 9362 (technique failure); 4428 (cure of peritonitis)

Model building Model 1 Model 2 Model 3 only centre (random effect) intercept only model obtain estimate for risk each centre & sd (sd1) relating to variation Model 2 Model 1+ add patient characteristics (fixed effects) obtain estimate for each centre & sd (sd2) relating to variation % reduction in variation = (sd1-sd2)/sd1 Model 3 Model 2 + add centre characteristics (as fixed effect) obtain estimate for each centre & sd (sd3) relating to variation Further % reduction = (sd2-sd3)/sd2

Methods Patient characteristics: Age, gender, race and diabetes + (patient level model) Centre characteristics: Centre size, PD %, APD exposure, icodextrin exposure, PET performance, and analysis-specific factors 1st and 4th quartile compared with combined 2nd and 3rd quartile

Peritonitis rates

Centre Variation in Peritonitis Rates Unadjusted Patient-adjusted Facility-adjusted 16% patient 34% centre Variation in incidence rate of peritonitis across 51 Australian peritoneal dialysis centers during the period of 2003-2013 in unadjusted (green diamond), patient-level adjusted (red triangle) and patient- and center-level adjusted models (blue circle) with standard errors. Dialysis centers are ranked by incidence rate Nadeau-Fredette et al PDI 2016 36: 509-518

Centre characteristics : Peritonitis risk Center-level characteristics Variation across centers (n=51) Center size (total patient-years of follow-up) 220 (113-425) Percentage of PD (versus overall dialysis population) 20% (16%-26%) Transplantation center (n, %) 19 (37%) APD treatments exposure (% patients in center) 73% (49%-85%) Icodextrin solution exposure (% patients in center) 46% (30%-56%) Biocompatible solutions exposure (% patients in center) 2% (0%-10%) PET performed at PD initiation (% patients in center) 54% (36%-62%) Anti-fungal prophylaxis tis (% peritonitis in center) 64% (24%-82%) Hospitalisation for peritonitis (% peritonitis in center) 49% (28%-62%) Catheter removal with peritonitis (% peritonitis in center) 20% (15%-24%) Nadeau-Fredette et al PDI 2016 36: 509-518

Centre characteristics associated with peritonitis risk Smaller centre size, higher % of PD, lower rates of PET performance at PD start and lower % of hospitalisation for peritonitis were assocaited with a lower peritonitis count. In contrast a lower % of APD exposure, greater icodextrin exposure and lower or higher use of antifungal prophylaxis at time of peritonitis were associated with a higher peritonitis risk Nadeau-Fredette et al PDI 2016 36: 509-518

Technique Failure

Centre Variation in Technique Failure 7 fold variation 28% patient 53% centre Unadjusted Patient-adjusted Facility-adjusted Hazard rate Figure 1. Variation in hazard of technique failure across 51 Australian peritoneal dialysis centers during the period of 2004-2014 unadjusted (green diamond), patient-level adjusted (red triangle) and patient- and center-level adjusted models (blue circle) with standard errors. Dialysis centers are ranked by hazard rate of peritonitis Average technique failure: 0.35 episodes /pt-yr Htay…Johnson Clin J Am Soc Nephrol 2017; 12: 1090-1099

Center characteristics associated with technique failure Adjusted analyses % Patients on PD also predictive Technique failure was significantly less in centres with higher % of PD patients and larger centres; and more likely in centres with lower proportions of patients achieving baseline serum phosphate levels in target Htay et al ; Clin J Am Soc Nephrol 2017; 12: 1090-1099

Peritonitis Cure with antibiotics Paper under review

Conclusions 1 Centre characteristics accounted for important variation in risk of peritonitis, technique failure, and cure of peritonitis with antibiotics Whether these factors are directly related to the outcomes or relate to surrogate markers for other characteristics of units is uncertain

Conclusions 2 More methodological research is required More information on centre factors that may influence important outcomes is required

Acknowledgements All registry contributors: patients and health professionals Annie Claire Nadeau-Fredette: Baxter Healthcare Clinical Evidence Council (CEC) research grant Htay Htay : Health Manpower Development Plan fellowship award co-sponsored by MOH and Singhealth (Singapore) BEAT CKD NHMRC program grant ANZData registry staff PD working group of ANZData NHMRC fellowships: Johnson and Cho